IBB iShares Nasdaq Biotechnology Index Fund. Data is currently not available. DATA AS OF Feb 06, 2020 6:53 PM ET - AFTER HOURS. $122.46 0.01 0.01%. CLOSED AT 4:00 PM ET ON Feb 06, 2020. See how IBB has performed including trailing returns and dividend history. Mutual Funds Stocks ETFs Bonds Best Investments S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes Benchmark (%) Index: Nasdaq Biotechnology Index(R). On 4/3/14, IBB changed to the total return version of the Nasdaq Biotechnology index from the price return version. Historical index data has been restated to the total return version of the index since index inception on 9/24/03. Fund expenses, including management fees and other expenses Unlike mutual funds, ETF shares are bought and sold at market price, which may be higher or lower than their NAV, and are not individually redeemed from the fund. *The chart illustrates the NAV performance of a hypothetical $10,000 investment made in the fund on 12/31/1999 or on commencement of operations (whichever is later). IBB began trading in 2001 and has a slightly higher expense ratio of 0.47%. A tracker fund is an index fund that tracks a broad market index or a segment thereof. more.
Find the latest iShares Nasdaq Biotechnology In (IBB) stock quote, history, news and other vital information to help you with your stock trading and investing. IBB provides exposure to biotech and pharmaceutical companies and tracks a market capitalization -weighted index of companies listed on the Nasdaq exchange. IBB began trading in 2001 and has a Stock quote for iShares Nasdaq Biotechnology Index Fund Common Stock (IBB) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. The NASDAQ Biotechnology Index contains securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceuticals. Fund Summary for IBB ISHARES NASDAQ BIOTECHNOLOGY ETF
Learn about IBB with our data and independent analysis including price, star rating, asset allocation, capital gains, and dividends. Start a 14-day free trial to�
Learn about IBB with our data and independent analysis including price, star rating, asset allocation, capital gains, and dividends. Start a 14-day free trial to Morningstar Premium to unlock our Fund Summary for IBB ISHARES NASDAQ BIOTECHNOLOGY ETF The iShares Nasdaq Biotechnology ETF seeks investment results that correspond generally to the price and yield performance, before fees and Learn everything you need to know about iShares Nasdaq Biotechnology ETF (IBB) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it
Benchmark (%) Index: Nasdaq Biotechnology Index(R). On 4/3/14, IBB changed to the total return version of the Nasdaq Biotechnology index from the price return version. Historical index data has been restated to the total return version of the index since index inception on 9/24/03. Find the latest quotes for iShares Nasdaq Biotechnology Index Fund (IBB) as well as ETF details, charts and news at Nasdaq.com. IBB | A complete iShares Nasdaq Biotechnology ETF exchange traded fund overview by MarketWatch. View the latest ETF prices and news for better ETF investing. IBB Fund Description IBB tracks the performance of a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. IBB Factset Analytics Insight Learn about IBB with our data and independent analysis including price, star rating, asset allocation, capital gains, and dividends. Start a 14-day free trial to Morningstar Premium to unlock our